FierceBiotech ١٩ مارس ٢٠٢٦ Phage-focused BiomX resets after adverse events derail pipeline, considers pivot to defense sector
FierceBiotech ١٩ مارس ٢٠٢٦ Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’
FierceBiotech ١٩ مارس ٢٠٢٦ Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trial
FierceBiotech ١٩ مارس ٢٠٢٦ Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress
FierceBiotech ١٨ مارس ٢٠٢٦ Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome
FierceBiotech ١٨ مارس ٢٠٢٦ JenaValve's Trilogy valve secures FDA's 1st approval in aortic regurgitation
FierceBiotech ١٧ مارس ٢٠٢٦ Xaira exec divulges R&D focus, how $1B fundraise fuels AI-driven hunt for what the 'industry is hungriest for'
FierceBiotech ١٧ مارس ٢٠٢٦ FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings
FierceBiotech ١٧ مارس ٢٠٢٦ Hitting regulatory roadblock, Bicycle pumps brakes on lead program and deflates headcount by 30%
FierceBiotech ١٧ مارس ٢٠٢٦ BioVie plans $20M IPO for spinout tasked with developing liver disease drug
FierceBiotech ١٧ مارس ٢٠٢٦ R1 zooms out of stealth with $77.5M series A to advance chronic kidney disease treatment
FierceBiotech ١٧ مارس ٢٠٢٦ Roche inks Nvidia deal to bolster AI factory, speed up drug and diagnostic development